Corrigendum to "Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?" [Thromb. Res. 236 (2024) 236-239 TR_8963].

Thromb Res

Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium; QUALIresearch, QUALIblood s.a., Namur, Belgium; Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Fe

Published: August 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2024.109066DOI Listing

Publication Analysis

Top Keywords

corrigendum "asundexian
4
"asundexian atrial
4
atrial fibrillation
4
fibrillation pharmacodynamic
4
pharmacodynamic data
4
data explain
4
explain failure?"
4
failure?" [thromb
4
[thromb res
4
res 236
4

Similar Publications

Corrigendum to "Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?" [Thromb. Res. 236 (2024) 236-239 TR_8963].

Thromb Res

August 2024

Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium; QUALIresearch, QUALIblood s.a., Namur, Belgium; Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Fe

View Article and Find Full Text PDF